Dashboard
1
With ROE of 17.40%, it has a attractive valuation with a 1.52 Price to Book Value
- Over the past year, while the stock has generated a return of 11.79%, its profits have risen by 38.7% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 2.3
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.91%
0%
11.91%
6 Months
-8.64%
0%
-8.64%
1 Year
15.13%
0%
15.13%
2 Years
81.19%
0%
81.19%
3 Years
17.8%
0%
17.8%
4 Years
34.69%
0%
34.69%
5 Years
91.69%
0%
91.69%
Star Lake Bioscience Co., Inc. Zhaoqing Guangdong for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
75.06%
EBIT Growth (5y)
62.25%
EBIT to Interest (avg)
10.68
Debt to EBITDA (avg)
1.28
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
1.52
Tax Ratio
22.50%
Dividend Payout Ratio
66.94%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.19%
ROE (avg)
11.94%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.52
EV to EBIT
8.86
EV to EBITDA
6.02
EV to Capital Employed
1.36
EV to Sales
0.94
PEG Ratio
0.08
Dividend Yield
2.27%
ROCE (Latest)
15.39%
ROE (Latest)
17.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
3,917.80
4,303.20
-8.96%
Operating Profit (PBDIT) excl Other Income
207.20
511.70
-59.51%
Interest
11.50
25.00
-54.00%
Exceptional Items
-1.60
-53.70
97.02%
Consolidate Net Profit
175.60
171.60
2.33%
Operating Profit Margin (Excl OI)
52.90%
69.90%
-1.70%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -8.96% vs -3.56% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 2.33% vs -34.50% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
17,307.30
17,364.30
-0.33%
Operating Profit (PBDIT) excl Other Income
2,415.40
2,022.60
19.42%
Interest
117.00
182.40
-35.86%
Exceptional Items
-336.40
-159.90
-110.38%
Consolidate Net Profit
949.80
685.70
38.52%
Operating Profit Margin (Excl OI)
90.60%
67.20%
2.34%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -0.33% vs -0.50% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 38.52% vs -42.04% in Dec 2023
About Star Lake Bioscience Co., Inc. Zhaoqing Guangdong 
Star Lake Bioscience Co., Inc. Zhaoqing Guangdong
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






